These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4599577)

  • 1. [Modification of cerebrovascular diseases through the oral administration of raubasine].
    Klein K; Grübl M
    Wien Med Wochenschr; 1974 Jun; 124(23):360-4. PubMed ID: 4599577
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evidence for the action of raubasine from a new formulation of Lamuran tablets].
    Glocke M; Grübl M; Klein K; Teufel W
    Med Klin; 1976 Sep; 71(38):1564-8. PubMed ID: 790125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of gamma-aminobutyric acid preparations on cerebral circulation in chronic cerebrovascular insufficiency].
    Eninia GI; Smeltere ES; Godlevska MA; Uzulinia IP
    Klin Med (Mosk); 1982 Oct; 60(10):47-50. PubMed ID: 7176473
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic principles of therapygin cerebrovascular diseases].
    Klein K
    Med Klin; 1973 May; 68(18):572-9. PubMed ID: 4576604
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute effect of intravenous administration of raubasine on the peripheral pulse in patients with diabetic arterial diseases].
    Calcaterra V
    Minerva Cardioangiol; 1973; 21(7):530-44. PubMed ID: 4756347
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine].
    Henriet M; Jacquy J; Noel G
    Brux Med; 1974 Dec; 54(12):743-5. PubMed ID: 4215548
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of dihydroergotamine in patients with orthostatic dystonia].
    Rieger P; Slany E
    Wien Med Wochenschr; 1970 May; 120(18):338-44. PubMed ID: 5490869
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regional cerebrovascular circulation. Measurement technics, regulation, changes in cerebrovascular disorders, and pharmacologic modification].
    Herrschaft HF
    Schriftenr Neurol; 1975; 15():1-239. PubMed ID: 1228883
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vasoactive combination treatment in cerebrovascular sclerosis].
    Klein K
    Wien Med Wochenschr; 1973 Jan; 123(1):14-8. PubMed ID: 4405190
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the demonstration of drug effects on the brain circulation].
    Klein K
    Med Welt; 1967 Sep; 35():2021-5. PubMed ID: 5595992
    [No Abstract]   [Full Text] [Related]  

  • 11. [Trial of using Cavinton in cerebrovascular disorders].
    Shtok VN; Eremeeva SV
    Klin Med (Mosk); 1982 Oct; 60(10):39-42. PubMed ID: 6757560
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of cyclandelate on cerebral circulation. A double blind trial with clinical and radiocirculographic investigations.
    Eichhorn O
    Vasc Dis; 1965 Nov; 2(6):305-15. PubMed ID: 5323511
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
    Lefebvre P; Crocq L; Bernard JG
    Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK; Blechacz W
    Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebrovascular circulation and cephalic hypertension].
    Siedek H; Klein K
    Wien Med Wochenschr; 1969 Feb; 119(7):135-7. PubMed ID: 5772003
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
    Andalò L; Missana M
    Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulatory effect of kallikrein; with special reference to cerebral circulation.
    Miyazaki M
    Adv Exp Med Biol; 1989; 247B():607-10. PubMed ID: 2610098
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of raubasine in long-term therapy of obliterating arteriopathies].
    Andreozzi GM; Signorelli S; Magnano V; Savoca N; Mazzerbo A; Cottini E; Sorrentino F
    Minerva Cardioangiol; 1979; 27(1-2):61-6. PubMed ID: 471237
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of Hexobendine on regional cerebral blood flow in stroke patients.
    McHenry LC; Jaffe ME; Kawamura J; Goldberg HI
    Neurology; 1970 Apr; 20(4):375. PubMed ID: 5534978
    [No Abstract]   [Full Text] [Related]  

  • 20. [Deendence of intraocular pressure on blood pressure, circulatory volume, and resistance to flow (clinical and experimental animal studies].
    Sayegh F
    Adv Ophthalmol; 1975; 29():185-9. PubMed ID: 805514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.